Calamos Advisors LLC lessened its stake in shares of Caterpillar Inc. (NYSE:CAT – Free Report) by 11.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 156,253 shares of the industrial products company’s stock after selling 19,528 shares during the period. Calamos […]
Axxcess Wealth Management LLC boosted its holdings in shares of Caterpillar Inc. (NYSE:CAT – Free Report) by 1.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,437 shares of the industrial products company’s stock after buying an additional 96 shares during the […]
Delta Financial Group Inc. increased its holdings in shares of Microsoft Co. (NASDAQ:MSFT – Free Report) by 0.3% during the 1st quarter, Holdings Channel.com reports. The fund owned 49,360 shares of the software giant’s stock after acquiring an additional 125 shares during the period. Microsoft accounts for about 5.6% of Delta Financial Group Inc.’s portfolio, […]
Arrow Financial Corp boosted its position in shares of Caterpillar Inc. (NYSE:CAT – Free Report) by 16.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,389 shares of the industrial products company’s stock after acquiring an additional 2,275 shares during the quarter. Arrow […]
CFO4Life Group LLC decreased its holdings in Caterpillar Inc. (NYSE:CAT – Free Report) by 7.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 910 shares of the industrial products company’s stock after selling 78 shares during the quarter. CFO4Life Group LLC’s […]
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Barclays from $127.00 to $132.00 in a report issued on Monday, MarketBeat reports. Barclays currently has an overweight rating on the healthcare product maker’s stock. Several other analysts have also recently weighed in on ABT. Raymond James lifted their price objective on Abbott […]
Financial Counselors Inc. lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,365 shares of the healthcare product maker’s stock after selling 3,764 shares during the period. Financial […]
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price objective boosted by equities researchers at Barclays from $127.00 to $132.00 in a research note issued on Monday, FlyOnTheWall reports. Barclays‘s price target suggests a potential upside of 15.50% from the company’s previous close. ABT has been the topic of a number of other reports. […]
Venturi Wealth Management LLC decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,021 shares of the healthcare product maker’s stock after selling 406 shares during the period. Venturi Wealth Management LLC’s holdings […]
Delta Financial Group Inc. raised its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,774 shares of the company’s stock after purchasing an additional 467 shares during the period. Johnson & Johnson […]